Pyxis Oncology, Inc. (PYXS) Live Share Price, Invest From India

Pyxis Oncology, Inc. Stock Performance

as on February 28, 2026 at 7:59 am IST

Day's Low
Day's High
$1.46
Day's Price Range
$1.52
$1.48
1.35%
Downside
2.70%
Upside
52 Week's Low
52 Week's High
$0.83
52-Week Price Range
$5.55
$1.48
43.70%
Downside
275.00%
Upside

Pyxis Oncology, Inc. share price movements today

Previous Close: $1.52
Open: $1.49
Volume: 264.8K
Day's Low - High: $1.46 - $1.52
52 Week Low - High: $0.83 - $5.55

Pyxis Oncology, Inc. Historical Returns

1 Month Return: -2.65 %
3 Month Return: -71.68 %
1 Year Return: + 23.53 %
3 Year Return: -35.24 %
5 Year Return: 0 %

Pyxis Oncology, Inc. Stock Fundamentals & Key Indicators

Check Pyxis Oncology, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$94.6M

EPS (TTM)

-1.3111

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-80.5M

Revenue (TTM)

2.8M

Profit Margin

0.00%

Return On Equity TTM

-87.28%

Pyxis Oncology, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Pyxis Oncology, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Pyxis Oncology, Inc.	BUY	$94.6M	NA	NA	0.00%
Vertex Pharmaceuticals Incorporated	BUY	$122.0B	133.75%	31.34	32.94%
Alnylam Pharmaceuticals, Inc.	BUY	$43.9B	124.79%	142.78	8.45%
Beone Medicines Ltd	NA	$35.7B	NA	619.94	1.38%
Regeneron Pharmaceuticals, Inc.	BUY	$81.5B	73.48%	18.59	31.41%

Stock Returns calculator for Pyxis Oncology, Inc. Stock including INR - Dollar returns

The Pyxis Oncology, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Pyxis Oncology, Inc. investment value today

Current value as on today

₹1,28,674

Returns

₹28,674

(+28.67%)

Returns from Pyxis Oncology, Inc. Stock

₹24,370 (+24.37%)

Dollar Returns*

₹4,304 (+4.3%)

Analyst Recommendation on Pyxis Oncology, Inc. Stock

Based on 13 analysts

BUY

92.31%

Buy

7.69%

Hold

0.00%

Sell

Based on 13 analysts, 92.31% of analysts recommend a 'BUY' rating for Pyxis Oncology, Inc.. Average target price of $6.92

Pyxis Oncology, Inc. Share Price Target

Get share price movements and forecasts by analysts on Pyxis Oncology, Inc..

What analysts predicted

78.61%UPSIDE

Target Price

$6.92

Current Price

$1.48

Analyzed by

13 Analysts

Target

$6.92

Pyxis Oncology, Inc. target price $6.92, a slight upside of 78.61% compared to current price of $1.48. According to 13 analysts rating.

Pyxis Oncology, Inc. Stock’s Investor Sentiment and Interest

Search interest for Pyxis Oncology, Inc. Stock has decreased by -54% in the last 30 days, reflecting a downward trend in search activity.

Time period: January 30, 2026 to March 1, 2026

Change:-54% versus previous 30 day period

Pyxis Oncology, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	-	-	3	16	-	-	3	-	2	-
Gross Profit	0	0	2	15	0	0	1	0	2	-
Operating Income	-18	-25	-17	-5	-20	-23	-40	-22	-19	-23
EBITDA	-17	-24	-17	-4	-19	-23	-18	-22	-19	-21
Interest Expense	-	-	1	-	-	-	-	-	-	-
Depreciation	0	0	0	1	0	0	0	0	0	0
Income Before Tax	-15	-23	-15	-3	-17	-21	-37	-21	-18	-22
Income Tax Expense	-1	0	3	1	-	-	-2	-	0	-
Net Income	-15	-23	-15	-3	-17	-21	-35	-21	-18	-22
Net Profit Margin	0.00%	0.00%	-456.05%	-20.17%	0.00%	0.00%	-1045.59%	0.00%	-650.85%	0.00%

Pyxis Oncology, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	16
Gross Profit	-	0	-1	-1	-2	15
Operating Income	-2	-12	-69	-123	-82	-89
EBITDA	-2	-12	-69	-122	-80	-65
Interest Expense	-	-	6	2	-	-
Depreciation	-	0	0	0	1	2
Income Before Tax	-2	-12	-75	-120	-73	-79
Income Tax Expense	0	0	5	-2	1	-2
Net Income	-2	-12	-75	-117	-73	-77
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	-478.95%

Pyxis Oncology, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	-23	-15	-3	-17	-21	-35	-21	-18	-22
Operating Cash Flow	-17	-15	-20	-3	-14	-19	-22	-17	-13
Investing Cash Flow	6	10	-18	0	0	26	15	15	11
Financing Cash Flow	0	0	57	0	1	0	-	0	0
Change in Cash	-11	-5	18	-2	-13	7	-6	-2	-1

Pyxis Oncology, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-12	-75	-120	-73	-77
Operating Cash Flow	-10	-35	-89	-70	-57
Investing Cash Flow	-1	0	-6	-104	8
Financing Cash Flow	0	304	0	5	59
Change in Cash	-11	268	-95	-169	9

Global Institutional Holdings in Pyxis Oncology, Inc.

Funds	Holdings
TANG CAPITAL MANAGEMENT LLC	4.03%
BlackRock Inc	1.49%
Aberdeen Group PLC	1.47%
Jane Street Group LLC	0.54%
Schulhoff & CO Inc	0.44%

See all

Insights on Pyxis Oncology, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 70.4% return, outperforming this stock by 109.7%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 34.9% return, outperforming this stock by 11.4%
NEGATIVE IMPACT
Price Dip
In the last 3 months, PYXS stock has moved down by -66.5%

About Pyxis Oncology, Inc.

pyxis oncology is developing antibody therapeutics to promote the body's immune response to cancer, based on new insights into the tumor micro-environment.

Organisation	Pyxis Oncology, Inc.
Headquarters	321 Harrison Avenue, Boston, MA, United States, 02118
Industry	Services
CEO	Mr. Thomas Civik
E-voting on shares	Click here to vote

Key Management of Pyxis Oncology, Inc.

Name	Title
Mr. Jitendra Wadhane C.A., CPA	Chief Accounting Officer, Senior VP of Finance, Corporate Controller & Principal Financial Officer
Dr. Jan Pinkas Ph.D.	Chief Scientific Officer
Mr. Alex Kane M.B.A.	Senior Vice President of Investor Relations & Capital Markets
Mr. Stephen T. Worsley MBA	Senior VP & Chief Business Officer
Mr. Thomas Civik	Interim CEO & Director
Dr. Balu N. Balasubramanian Ph.D.	Interim Chief Technology Officer
Donna Regalado	Head of Human Resources
Dr. Charles T. Gombar Ph.D.	Senior Vice President of Portfolio & Program Management
Dr. Michael Bui	Head of Global Regulatory Affairs
Dr. Supriya Roth Ph.D.	Head of Commercial Development

FAQs

What is Pyxis Oncology, Inc. share price today?

Pyxis Oncology, Inc. share price today is $1.48 as on February 28, 2026 at 2:29 am IST at the close of the market. Pyxis Oncology, Inc. share today touched a day high of $1.52 and a low of $1.46.

What is the 52 week high and 52 week low for Pyxis Oncology, Inc. share?

Pyxis Oncology, Inc. share touched a 52 week high of $5.55 on November 26, 2025 and a 52 week low of $0.83 on April 7, 2025. Pyxis Oncology, Inc. stock price today i.e. February 28, 2026 at 2:29 am IST is closed at $1.48,which is 73.33% down from its 52 week high and 77.63% up from its 52 week low.

What is Pyxis Oncology, Inc.'s market capitalisation today?

Pyxis Oncology, Inc. market capitalisation is $0.00T as on February 28, 2026 at 2:29 am IST.

How to invest in Pyxis Oncology, Inc. Stock (PYXS) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Pyxis Oncology, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pyxis Oncology, Inc. Shares that will get you 1.0135 shares as per Pyxis Oncology, Inc. share price of $1.48 per share as on February 28, 2026 at 2:29 am IST.

What is the minimum amount required to buy Pyxis Oncology, Inc. Stock (PYXS) from India?

Indian investors can start investing in Pyxis Oncology, Inc. (PYXS) shares with as little as ₹91.026 or $1 (as of March 1, 2026 at 10:38 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹910.26 in Pyxis Oncology, Inc. stock (as per the Rupee-Dollar exchange rate as on March 1, 2026 at 10:38 pm IST). Based on Pyxis Oncology, Inc. share’s latest price of $1.48 as on February 28, 2026 at 2:29 am IST, you will get 6.7568 shares of Pyxis Oncology, Inc.. Learn more about fractional shares .